This is a preview of subscription content, log in via an institution to check access.
Notes
Supported by Biogen Idec Inc.
Reference
Kita M, et al. Effects of BG-12 (Dimethyl Fumarate) on Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies. 65th Annual Meeting of the American Academy of Neurology : abstr. P07.092, 16 Mar 2013.
Rights and permissions
About this article
Cite this article
Dimethyl fumarate provides better QOL in RRMS. PharmacoEcon Outcomes News 674, 9 (2013). https://doi.org/10.1007/s40274-013-0255-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0255-3